Innovation and Entrepreneurship (I&E)

New York Times reporter Steve Lohr highlights the technology startup Ultranauts, which was founded by two MIT graduates and follows a “distinctive set of policies and practices to promote diversity and inclusion among employees.”

Writing for Wired, Ash Carter, an innovation fellow at the MIT Innovation Initiative, spotlights a number of “technologists, activists, and policymakers who are thoughtfully creating and using technology in ways to protect the public good and help shape a better future.”

Fast Company reporter Steven Melendez spotlights Minglr, an open-source tool that is aimed at connecting attendees at virtual conferences for brief video conversations. “If you’re in a group like a conference, one thing people might do is contact people they know,” says Prof. Thomas Malone. “Other people could contact people they have heard of but not met.”

Writing for Forbes, Pooja Wagh of MIT Solve examines how the Covid-19 pandemic has “highlighted the urgency of human-centric innovations in global health and the need for those solutions to be driven by the communities they serve.” 

Engine CEO Katie Rae speaks with Arielle Pardes of Wired about the need to invest in companies that are tackling the world’s most urgent problems. “We back transformational technology that could shape a market and solve a huge world problem all in a go,” says Rae. “But it requires patience, it requires capital and it requires imagination on how to get these types of companies to market.”

Quartz reporter Ananya Bhattacharya spotlights a new study co-authored by Prof. Pierre Azoulay that examines the role of immigration in entrepreneurship, and finds that immigrants in the U.S. act more as “job creators” than as “job takers.”

WHDH spotlights MIT startup E25Bio, which is developing a new rapid test to diagnose Covid-19. The test being developed by E25Bio is a paper strip that can deliver test results in 15 minutes, WHDH explains.

President L. Rafael Reif joins Alan Alda on his podcast “Clear + Vivid” to discuss the need for increased American investment in fundamental research and development.

The Economist spotlights a recent essay by Prof. David Autor and Elisabeth Reynolds, executive director of the MIT Task Force on the Work of the Future, about the impact of the coronavirus pandemic on the state of work. “If remote working proves a lasting shift, then the café staff, taxi drivers and cleaners who depend on their custom could find themselves out of work,” writes The Economist.

Reporting for USA Today, Karen Weintraub spotlights how researchers from MIT and 3M are collaborating on a rapid, low-cost diagnostic test for Covid-19. "The world needs as many useful tests as possible as fast as possible," says Prof. Hadley Sikes.

TechCrunch reporter Zach Whittaker writes about Butlr, an MIT startup that has developed passive infrared sensors that use a “mix of wireless, battery-powered hardware and artificial intelligence to track people’s movements indoors without violating their privacy.”

Architects from MIT and Generate Technologies have designed Boston’s first cross-laminated timber (CLT) building, a “’revolutionary’ type of timber [that] promises to reduce emissions that cause climate change, create affordable housing and jumpstart a new job-producing, homegrown industry in New England,” reports Bruce Gellerman and Kathleen McNerney for WBUR.

CNBC reporter Will Feur spotlights how researchers from MIT are working with 3M on developing a rapid coronavirus antigen test. The test “will be a paper-based point-of-care testing device, which will help reduce the cost,” Feur explains.

Researchers from MIT and 3M are developing a new rapid antigen test for Covid-19, reports Carl O’Donnell for Reuters. “The test would produce results within minutes and could be administered on a low-cost, paper-based device, similar to a home pregnancy test, that could be delivered at the point of care,” writes O’Donnell.

TechCrunch reporter Darrell Etherington writes that researchers from MIT and 3M are working on creating a new diagnostic tool for Covid-19 that can be manufactured cheaply and in large volumes for mass distribution. “The goal is to create a test that detects viral antigens,” Etherington explains, adding that the tests “provide results much faster than the molecular PCR-based test.”